before testing. The remaining 43 patients were treated with risperidone (n = 11), aripriprazole (n = 10), ziprasidone (n = 9), olanzapine (n = 6), quetiapine (n = 4), or clozapine (n = 3), with chlorpromazine equivalents ranging from 67 to 1067 mg/day (Woods, 2003). The number of medicated and unmedicated patients did not differ between AH and NH subgroups for either paradigm (χ2[1] ≤ 1.18, p ≥ .28).
